跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
欣母沛 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Carboprost Tromethamine Injection
Approved
化学药品
Carboprost Tromethamine Injection
辉瑞
🇨🇳 National Medical Products Administration
Approval Date
Feb 22, 2022
Approval ID
8EflbPJz6TQ
Company
辉瑞
Type
化学药品
Approval Details
Approval Id
8EflbPJz6TQ
Approval Number
国药准字HJ20170146
Generic Name
卡前列素氨丁三醇注射液
Generic Name En
Carboprost Tromethamine Injection
Trade Name
欣母沛
Drug Type
化学药品
Dosage Form
注射剂
Strength
1ml:250μg
Reg Date
2022-02-22
Expired Date
2027-02-21
Company Name
辉瑞
Production Company Name
Pharmacia & Upjohn Company LLC
Company Detail Path
/organization/pfizer-cdr-cad-hedged
Production Company Detail Path
/organization/pharmacia-and-upjohn-company-llc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Feb 22, 2022
Approval ID
8EflbPJz6TQ
Type
化学药品
Back to NMPA Approvals